Skip to main content
Device Global Header

Subscribe
or Renew

Advanced Search

This article is available to subscribers. Subscribe now. Already have an account? Sign in

Review ArticleDrug Therapy

Migraine — Current Understanding and Treatment

List of authors.
  • Peter J. Goadsby, M.D., D.Sc.,
  • Richard B. Lipton, M.D.,
  • and Michel D. Ferrari, M.D., Ph.D.

Migraine is a common and sometimes debilitating disorder. This review describes the epidemiology, pathophysiology, and preventive and symptomatic treatment of migraine, with special attention to drug therapy with the triptans.

Continue reading this article

Select an option below:

Create your account to get 2 free subscriber-only articles each month.

Get Free Access Now Subscribe For Full Access

Already have an account?

Sign In

Print subscriber?

Activate your online access.

Funding and Disclosures

Dr. Goadsby is a Wellcome Senior Research Fellow.

Dr. Goadsby has received research grants from or served as a consultant to Abbott, Allergan, Almirall Prodesfarma, AstraZeneca, Bristol-Myers Squibb, Elan, Glaxo SmithKline, Merck, Ortho-McNeil, Pfizer, Pharmacia, Pierre Fabre, and Vanguard.

Dr. Lipton has received research grants or served as a consultant to Abbott, Allergan, American Home Products, AstraZeneca, Bristol-Myers Squibb, Elan, Glaxo SmithKline, Johnson & Johnson, Merck, Pfizer, Pharmacia, and Vanguard.

Dr. Ferrari has received research grants from or served as a consultant to Abbott, Allergan, Almirall Prodesfarma, AstraZeneca, Elan, Glaxo SmithKline, Merck, Pfizer, Pharmacia, and Pierre Fabre.

Author Affiliations

From the Institute of Neurology, National Hospital for Neurology and Neurosurgery, London (P.J.G.); the Departments of Neurology, Epidemiology, and Social Medicine, Albert Einstein College of Medicine and the Montefiore Headache Unit, New York (R.B.L.); Innovative Medical Research, Towson, Md. (R.B.L.); and the Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands (M.D.F.).

Address reprint requests to Professor Goadsby at the Institute of Neurology, Queen Sq., London WC1N 3BG, United Kingdom, or at .

Print Subscriber? Activate your online access.